Olmesartan Medoxomil is a synthetic imidazole-derived angiotensin II receptor antagonist, acting as a prodrug with an antihypertensive property.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Inhibition of Arachidonic acid (AA) metabolism by angiotensin II receptor blockers (ARBs) occurs in a concentration-dependent manner, with Olmesartan showing an IC50 of 66.2 μM[1]. Olmesartan medoxomil is identified as a potent, selective blocker of the angiotensin AT1 receptor[2]. |
体内研究 | The effectiveness of Olmesartan was evaluated in db/db diabetic mice over a 12-week period, starting from weeks 10 to 22 of age. These mice exhibited a significant increase in albuminuria (11.7-fold) compared to controls. Treatment with Olmesartan for twelve weeks notably reduced albuminuria by 77% versus placebo, and the albumin/creatinine ratio (ACR) saw a significant decrease by 59% in treated db/db mice, highlighting its potential benefits in diabetic conditions[3]. |
体外研究 | Inhibition of Arachidonic acid (AA) metabolism by angiotensin II receptor blockers (ARBs) occurs in a concentration-dependent manner, with Olmesartan showing an IC50 of 66.2 μM[1]. Olmesartan medoxomil is identified as a potent, selective blocker of the angiotensin AT1 receptor[2]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01271374 | Hypertension | Phase 4 | Unknown | December 2011 | United States, Georgia ... 展开 >> Atlanta Clinical Research Center Tucker, Georgia, United States, 30084 收起 << |
NCT01870739 | - | Completed | - | - | |
NCT02089399 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung medical center Seoul, Korea, Republic of 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.79mL 0.36mL 0.18mL |
8.95mL 1.79mL 0.90mL |
17.90mL 3.58mL 1.79mL |
CAS号 | 144689-63-4 |
分子式 | C29H30N6O6 |
分子量 | 558.585 |
别名 | CS 866 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Store in freezer, under -20°C |
溶解度 |
DMSO: 50 mg/mL(89.51 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |